Biote Corp. BTMD
Institutional shares held
16.9 Million
0
calls
0
puts
Total value of holdings
$65.8M
$0
calls
$0
puts
Market Cap
$29.4M
7,574,270
Shares Out.
Institutional ownership
223.75%
# of Institutions
89
We take great care to ensure that the data presented and summarized in this overview for biote Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BTMD
View all-
325 Capital LLC New York, NY4.55MShares$17.6 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$9.45 Million2.95% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$6.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$5.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA701KShares$2.72 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX652KShares$2.53 Million0.0% of portfolio
-
Boston Partners Boston, MA591KShares$2.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA575KShares$2.23 Million0.0% of portfolio
-
State Street Corp Boston, MA502KShares$1.95 Million0.0% of portfolio
-
Hillsdale Investment Management Inc. Toronto, A6338KShares$1.31 Million0.06% of portfolio
Latest Institutional Activity in BTMD
Top Purchases
Top Sells
About BTMD
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Insider Transactions at BTMD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2025
|
Debra L Morris |
BUY
Exercise of conversion of derivative security
|
Direct |
11,045
+18.05%
|
-
|
|
May 13
2025
|
Dana Lynn Jacoby |
BUY
Exercise of conversion of derivative security
|
Direct |
12,994
+16.88%
|
-
|
|
May 07
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,677
+0.25%
|
$35,031
$3.35 P/Share
|
|
May 06
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
436,037
+8.64%
|
$1,308,111
$3.26 P/Share
|
|
Apr 30
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,933
+0.05%
|
$5,799
$3.3 P/Share
|
|
Apr 21
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,801
+0.21%
|
$26,403
$3.27 P/Share
|
|
Apr 17
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,874
+0.16%
|
$20,622
$3.29 P/Share
|
|
Apr 16
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.02%
|
$3,000
$3.29 P/Share
|
|
Apr 09
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,532
+0.32%
|
$40,596
$3.21 P/Share
|
|
Apr 08
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
34,907
+0.84%
|
$104,721
$3.21 P/Share
|
|
Apr 07
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
43,378
+1.04%
|
$130,134
$3.15 P/Share
|
|
Apr 04
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,741
+0.58%
|
$71,223
$3.24 P/Share
|
|
Apr 03
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,321
+0.18%
|
$21,963
$3.24 P/Share
|
|
Mar 31
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
106,000
+2.56%
|
$318,000
$3.32 P/Share
|
|
Mar 17
2025
|
Andrew R Heyer |
BUY
Open market or private purchase
|
Indirect |
25,000
+6.33%
|
$75,000
$3.95 P/Share
|
|
Mar 17
2025
|
Andrew R Heyer |
BUY
Open market or private purchase
|
Direct |
50,000
+3.18%
|
$150,000
$3.95 P/Share
|
|
Mar 17
2025
|
Stephen Mark Cone |
BUY
Open market or private purchase
|
Direct |
38,104
+19.15%
|
$114,312
$3.88 P/Share
|
|
Mar 17
2025
|
Bret Christensen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,595
+50.0%
|
$112,785
$3.87 P/Share
|
|
Mar 17
2025
|
Marc D Beer Executive Chairman |
BUY
Open market or private purchase
|
Direct |
107,794
+50.0%
|
$323,382
$3.87 P/Share
|
|
Mar 17
2025
|
Guines LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100
+0.0%
|
$300
$3.74 P/Share
|
Last 12 Months Summary
Buy / Acquisition
1.9M
Shares
From
8
Insiders
| Open market or private purchase | 1.81M shares |
|---|---|
| Exercise of conversion of derivative security | 89K shares |
Sell / Disposition
44.3K
Shares
From
1
Insiders
| Open market or private sale | 44.3K shares |
|---|